A Double-blind RCT of a Single Dose of Hyaluronan in the Treatment of Osteoarthritis of the Ankle
Completed · Not applicable · Has a placebo group
Conditions studied: Osteoarthritis
In brief
To compare the therapeutic effect of single intra-articular injection of hyaluronate with a single intra-articular injection of normal saline (placebo) for osteoarthritis of the ankle.
Key facts
- Study ID
- NCT01243814
- Run by
- Henry DeGroot, M.D.
- People needed
- 69
- Starts
- 2009-10-01
- Expected to finish
- 2010-09-01
- Last updated by the study team
- 2012-03-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- To be eligible, subjects had to be at least 18 years old, not pregnant, and have pain and osteoarthritis of the ankle of at least stage 2 on the Kellgren and Lawrence scale.
- Their AOFAS score had to be 90 points or less out of a possible 100 points.
- Eligible subjects had to be willing to discontinue all pain medications and NSAIDs other than the rescue pain medications provided in the study.
You may not qualify if…
- Persons with systemic inflammatory condition or infection of the ankle or nearby soft tissues,
- an injection of steroid or surgery on the involved joint within 6 months,
- local cellulitis, rash, skin condition
- diabetic or neuropathic Charcot arthropathy,
- significant vascular insufficiency,
- current treatment with anticoagulants,
- lower extremity pain syndromes, sciatica, sprains, plantar fasciitis,
- significant ankle instability or malalignment,
- any known allergy to any of the components of either injection, known or suspected allergy to birds or bird products,
- disabling degenerative joint disease of the ipsilateral hip, knee or foot were ineligible for the study.
Where it is running
- The office of Dr. Henry DeGroot — Newton, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.